Human Sebocyte
897,00 CAD$*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Renseignements généraux
| Description | Human sebocyte cells are specialized epithelial cells derived from the sebaceous glands of the skin, which are holocrine glands associated with hair follicles and distributed throughout most cutaneous surfaces. Sebocytes are responsible for the synthesis, accumulation, and secretion of sebum, a complex mixture of lipids including triglycerides, wax esters, squalene, cholesterol esters, and free fatty acids. In vitro human sebocyte models are typically established either as primary cultures isolated from facial or scalp sebaceous glands or as immortalized sebocyte lines generated through defined genetic modifications to enable extended proliferation while retaining lipid-producing capacity. Phenotypically, human sebocytes display a characteristic differentiation program marked by progressive intracellular lipid droplet accumulation and enlargement of the cytoplasm prior to terminal holocrine secretion. They express epithelial and sebocyte-associated markers such as cytokeratins (e.g., K7, K8, K18), peroxisome proliferator-activated receptors (PPARα and PPARγ), sterol regulatory element-binding proteins (SREBPs), and enzymes involved in lipid biosynthesis including fatty acid synthase (FASN) and stearoyl-CoA desaturase. Sebocyte differentiation and lipogenesis are regulated by androgens, insulin-like growth factor-1 (IGF-1), retinoids, inflammatory cytokines, and Toll-like receptor signaling pathways. These cells also actively participate in innate immunity by producing antimicrobial peptides and pro-inflammatory mediators in response to microbial stimuli such as Cutibacterium acnes. Human sebocyte cell models are widely used in dermatological and cosmetic research to investigate acne pathogenesis, seborrheic dermatitis, androgen signaling, lipid metabolism, inflammatory signaling, and drug responses. They provide a controlled platform for evaluating the effects of hormonal modulation, retinoids, anti-androgens, PPAR agonists, and anti-inflammatory compounds on sebaceous gland biology. When using primary sebocytes, investigators must consider donor variability and limited lifespan, whereas immortalized sebocyte lines offer improved reproducibility but may exhibit altered differentiation kinetics compared to native sebaceous gland tissue. |
|---|---|
| Organisme | Human |
| Tissu | Face, skin, sebaceous gland |
| Applications | Dermatology research; acne pathogenesis; sebaceous lipid metabolism; androgen/IGF-1 signaling studies; inflammatory response studies; cosmetic and pharmaceutical screening; retinoid and anti-androgen testing |
| Synonymes | Primary human sebocytes; Human sebaceous gland cells |
Characteristics
More information on Age, Gender, Ethnicity in the CoA!
| Âge | Unspecified |
|---|---|
| Genre | Sex unspecified |
| Origine ethnique | Unspecified |
| Morphologie | epithelial-like |
| Type de cellule | Sebocyte |
| Propriétés de croissance | adherent |
Données réglementaires
| Référence | Human Sebocytes (Cytion catalog number 300696) |
|---|---|
| Niveau de biosécurité | 1 |
| NCBI_Numéro d'identification fiscale | 9606 |
Données biomoléculaires
Manipulation
| Milieu de culture | Sebocyte growth Medium |
|---|---|
| Réactif de dissociation | Accutase |
| Milieu de congélation | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Décongélation et culture des cellules |
|
| Atmosphère d'incubation | 37°C, 5% CO2, humidified atmosphere. |
| Conditions d'expédition | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Conditions d'entreposage | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Contrôle de la qualité et analyse moléculaire
| Stérilité | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificat d'analyse (CoA)
| Numéro de lot | Type de certificat | Date | Numéro de catalogue |
|---|---|---|---|
| 300696-SK0798 | Certificat d'analyse | 25. Feb. 2026 | 300696 |
| 300696-SK0752 | Certificat d'analyse | 25. Feb. 2026 | 300696 |
| 300696-SK0751 | Certificat d'analyse | 25. Feb. 2026 | 300696 |
| 300696-SK0747 | Certificat d'analyse | 25. Feb. 2026 | 300696 |
| 300696-SK0390 | Certificat d'analyse | 25. Feb. 2026 | 300696 |